600,000 lateral flow tests to be sent out this week to kick-start the significant expansion of testing, followed by weekly local allocations.
Over half a million rapid-turnaround lateral flow tests will be sent out by NHS Test and Trace to local public health leaders this week, signalling the next phase of the government’s plan to expand asymptomatic testing for COVID-19, the Prime Minister announced today.
Test kits will be issued to over 50 directors of public health across England this week, to enable local teams to direct and deliver community testing based on their local knowledge. Each will receive a batch of 10,000 antigen lateral flow devices as part of a new pilot to enable them to start testing priority groups.
Directors of public health will determine how to prioritise the allocation of these new tests, based on the specific needs of their communities, and will determine how people in the local area are tested. They will be supported by NHS Test and Trace to expand testing programmes in their area through access to training and clinical and operational guidance.
This initial 600,000 batch will then be followed up with a weekly allocation of lateral flow antigen tests. The Secretary of State for Health and Social Care has now written to all upper-tier local authority leaders, confirming that all directors of public health will be offered this weekly allocation, equivalent to 10% of their population. This will build on the existing partnerships between NHS Test and Trace and local leaders.
Directors of public health were prioritised for the first phase of rapid community testing based on the local prevalence of COVID-19 and expressions of interest to the Department of Health and Social Care (DHSC). Any director of public health who wants to start rolling out local testing using lateral flow tests can do so by contacting DHSC.
Proactively testing asymptomatic individuals will help identify those who unknowingly have the virus and enable those who test positive and their contacts to self-isolate, which can help drive down the R rate locally and save lives. This is crucial to break the chains of transmission of the virus and to support critical industries, key workers and institutions. With lower rates of transmission, those at highest risk from the virus will be more protected and residents will feel more confident in getting back to their day-to-day lives.
Health and Social Care Secretary, Matt Hancock, said:
This rollout will further develop the evidence base for how testing with fast, reliable COVID-19 tests can be delivered at scale. Local leaders will also benefit from a more accurate picture of the number of cases in their area, by picking up those who may not have symptoms, supporting local decision-making to manage the spread of the virus and support their communities.
This innovative new testing technology – which is already being rolled out as part of whole-city testing in Liverpool that began on Friday – can provide results within an hour without needing to be processed in a lab.
Liverpool has set up 16 testing sites for asymptomatic testing, a number of mobile test units and is delivering a significant number of home testing kits across the city.
Interim Executive Chair of the National Institute for Health Protection Baroness Dido Harding said:
Anyone who tests positive must self-isolate along with their household immediately and their contacts will be traced. Eligible individuals who test positive – and contacts who are required to self-isolate – will be entitled to the £500 Test and Trace Support Payment in the same way as a regular swab test ordered through NHS Test and Trace.
Those who test negative will need to continue to follow all national guidance.
Today’s announcement follows the Prime Minister’s commitment on 16 October that lateral flow antigen tests would soon be made available to directors of public health in England for them to direct and deliver an expansion of asymptomatic testing in line with local priorities.
The government has also committed to providing the Devolved Authorities with an allocation of lateral flow tests as they are made available, as part of UK-wide collaboration to stop the spread of the virus. Eligibility and deployment of testing in devolved administrations will be determined by the respective administrations.